Clinical trial · Interventional
PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers
PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum
NCT02408406CI-TRIAL-00078341completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This partially randomized pilot clinical trial develops and studies a software program, called PatientCareAnywhere, to see whether it can help patients communicate with their doctors and other healthcare providers, and educate themselves about their cancer and treatment options. A program that can help patients learn about their cancer and treatment options, and allows the patient's healthcare providers to receive their questionnaire results, may help patients identify and get help to treat their symptoms.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Carcinoma | Bladder Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Breast Carcinoma | Breast Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Colorectal Carcinoma | Colorectal Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Lung Carcinoma | Lung Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Malignant Female Reproductive System Neoplasm | Malignant Female Reproductive System Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Communication Intervention | Other | — | UNRESOLVED |
| Educational Intervention | Other | — | UNRESOLVED |
| Internet-Based Intervention | Other | — | UNRESOLVED |
| Quality-of-Life Assessment | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm I (PatientCareAnywhere program system)
- description
- Patients are encouraged to use the PatientCareAnywhere program at least once weekly either in the clinic or at home. Patients receive reminder emails after 1 week of inactivity. If patients indicate they are experiencing moderate to severe symptoms, an alert message is sent to at least 1 member of the patient's support team along with a list of expected response times.
- interventionNames
- Other: Communication Intervention
- Other: Educational Intervention
- Other: Internet-Based Intervention
- Other: Quality-of-Life Assessment
- Other: Questionnaire Administration
- type
- ACTIVE_COMPARATOR
- label
- Arm II (usual care)
- description
- Patients receive usual care, including a one-time use of SupportScreen, a touchscreen questionnaire system that identifies patient issues before appointments, at the clinic during the first treatment consultation after diagnosis. Consultation, printed education materials, and specialist referrals may be generated based on SupportScreen responses.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * PHASE I AIM 1 (STAKEHOLDER INPUT) * PHASE I AIM 1: Malignant diagnosis in any cancer type at any stage * PHASE I AIM 1: Receiving any type of cancer treatment * PHASE I AIM 1: Life expectancy of at least six months * PHASE I AIM 1: Current outpatient status * PHASE I AIM 1: Fluent in English * PHASE I AIM 1: Internet access at home * PHASE I AIM 3.1 (EVALUATION STUDY) * PHASE I AIM 3.1: Malignant diagnosis in any cancer type at any stage * PHASE I AIM 3.1: Receiving any type of cancer treatment * PHASE I AIM 3.1: Life expectancy of at least six months * PHASE I AIM 3.1: Current outpatient status * PHASE I AIM 3.1: Fluent in English * PHASE I AIM 3.1: Internet access at home * PHASE I AIM 3.2 (PILOT STUDY) * PHASE I AIM 3.2: Malignant diagnosis in breast, gynecologic (GYN), genitourinary (GU) cancer at any stage * PHASE I AIM 3.2: Receiving surgery and/or chemotherapy treatment * PHASE I AIM 3.2: Life expectancy of at least six months * PHASE I AIM 3.2: Current outpatient status (participation will be suspended during hospitalization) * PHASE I AIM 3.2: Fluent in English * PHASE I AIM 3.2: Internet access at home * PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL) * PHASE II AIM 2: Malignant diagnosis of breast, lung, or colorectal cancer at any stage * PHASE II AIM 2: Receiving any type of cancer treatment * PHASE II AIM 2: Life expectancy of at least six months * PHASE II AIM 2: Current medical oncology outpatient status (participation will be suspended during hospitalization) * PHASE II AIM 2: Fluent in English * PHASE II AIM 2: Internet access at home Exclusion Criteria: * PHASE I AIM 1 (STAKEHOLDER INPUT) EXCLUSION * PHASE I AIM 1: Clinical evidence of cognitive or psychological impairment * PHASE I AIM 1: Prisoners and pregnant women * PHASE I AIM 3.1 (EVALUATION STUDY) EXCLUSION * PHASE I AIM 3.1: Clinical evidence of cognitive or psychological impairment * PHASE I AIM 3.1: Prisoners and pregnant women * PHASE I AIM 3.2 (PILOT STUDY) EXCLUSION * PHASE I AIM 3.2: Clinical evidence of cognitive or psychological impairment * PHASE I AIM 3.2: Prisoners and pregnant women * PHASE I AIM 3.2: Currently participating in other psychosocial studies * PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL) EXCLUSION * PHASE II AIM 2: Clinical evidence of cognitive or psychological impairment * PHASE II AIM 2: Prisoners and pregnant women * PHASE II AIM 2: Currently participating in other psychosocial studies
References
Publications (1)
- DERIVEDBaik SH, Clark K, Sanchez M, Loscalzo M, Celis A, Razavi M, Yang D, Dale W, Haas N. Usability and Preliminary Efficacy of an Adaptive Supportive Care System for Patients With Cancer: Pilot Randomized Controlled Trial. JMIR Cancer. 2024 Jul 10;10:e49703. doi: 10.2196/49703. PMID 38986134